References
- Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.1 (09.07.2015). Association of the Nordic Cancer Registries. Danish Cancer Society. [Internet]; 2015. Available from: http://www.ancr.nu
- sst.dk[internet]. København: Sundhedsstyrelsen;c1928–2016. [updated 2014 oct 2; cited 2015 jan 12]. 2015. Available from: https://www.cancer.dk/fagfolk/screening/brystkraeft/
- Foged T, Sørensen JA, Søe KL, et al. Lack of nationwide Danish guidelines on mammography before non-oncological breast surgery. Dan Med J. 2015;62:A5076.
- patobank.dk. København: Danske regioner;c1999–2017[updated 2017; cited 2017 july 5]. 2017. Available from: http://www.patobank.dk/
- Viana GAP, Pitanguy I, Torres E. Histopathological findings in surgical specimens obtained from reduction mammaplasties. Breast. 2005;14:242–248.
- Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009;124:1033–1039.
- Goyal A, Coulson SG, Wu JM, et al. Occult breast carcinoma in breast reduction specimens in European women. Breast Cancer Res Treat. 2011;128:749–753.
- Hassan FE, Pacifico MD. Should we be analyzing breast reduction specimens? A systematic analysis of over 1000 consecutive cases. Aesth Plast Surg. 2012;36:1105–1113.
- Ambaye AB, MacLennan SE, Goodwin AJ, et al. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg. 2009;124:1386–1392.
- Colwell AS, Kukreja J, Breuing KH, et al. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg. 2004;113:1984–1988.
- Desouki MM, Li Z, Hameed O, et al. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women’s health centers. Hum Pathol. 2013;44:1877–1881.
- Cook IS, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J Clin Pathol. 2004;57:286–289.
- Boice JD, Friis S, McLaughlin JK, et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control. 1997;8:253–258.
- Schantz PAM, Jahkola TA, Krogerus LA, et al. Should we routinely analyse reduction mammaplasty specimens? J Plast Recon Aesth Surg. 2017;70:196–202.
- dbcg.dk[internet]. København: Danish Breast Cancer Cooperative Group; c1976-2016[updated 2015 nov 30; cited 2015 dec 10]. 2006. Available from: http://www.dbcg.dk/DBCG%20Retningslinier.htm
- Fryzek JP, Ye W, Nyrén O, et al. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women. Breast Cancer Res Treat. 2006;97:131–134.
- Brown MH, Weinberg M, Chong N, et al. A cohort study of breast cancer risk in breast reduction patients. Plast Reconstr Surg. 1999; 103:1674–1681.
- Nielsen M, Thomsen JL, Primdahl S, et al. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56:814–819.